Siga Technologies (SIGA) Common Equity (2010 - 2025)
Siga Technologies (SIGA) posted Common Equity of $198.8 million for Q4 2025, down 2.29% on a QoQ basis from $203.5 million in Q3 2025, and down 7.87% year-over-year from $215.8 million in Q4 2024.
Siga Technologies (SIGA) Common Equity (2010 - 2025) Analysis & Trends
Siga Technologies' Common Equity history runs 16 years deep, the most recent figure standing at $198.8 million for Q4 2025.
- Quarterly Common Equity fell 7.87% year-over-year to $198.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $198.8 million (down 7.87% YoY) and the FY2025 annual result came in at $198.8 million, down 7.87% from the prior year.
- Common Equity was $198.8 million for Q4 2025 at Siga Technologies, down from $203.5 million in the prior quarter.
- Across five years, Common Equity topped out at $216.1 million in Q1 2025 and bottomed at $106.6 million in Q3 2021.
- A 5-year average of $166.2 million and a median of $168.6 million in 2022 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity surged 62.49% — and 2023, when it retreated 28.3%.
- Siga Technologies' Common Equity stood at $174.3 million in 2021, then retreated by 2.38% to $170.2 million in 2022, then rose by 15.69% to $196.9 million in 2023, then gained by 9.62% to $215.8 million in 2024, then decreased by 7.87% to $198.8 million in 2025.
- Business Quant data shows SIGA's Common Equity at $198.8 million in Q4 2025, $203.5 million in Q3 2025, and $209.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.93 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.23 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 3.23 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 47.38 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.90 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 56.13 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 3.41 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.50 Bn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | 198.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 198.82 Mn |
| Sep 30, 2025 | 203.48 Mn |
| Jun 30, 2025 | 209.31 Mn |
| Mar 31, 2025 | 216.13 Mn |
| Dec 31, 2024 | 215.80 Mn |
| Sep 30, 2024 | 169.44 Mn |
| Jun 30, 2024 | 167.56 Mn |
| Mar 31, 2024 | 164.99 Mn |
| Dec 31, 2023 | 196.86 Mn |
| Sep 30, 2023 | 124.14 Mn |
| Jun 30, 2023 | 124.07 Mn |
| Mar 31, 2023 | 162.09 Mn |
| Dec 31, 2022 | 170.16 Mn |
| Sep 30, 2022 | 173.14 Mn |
| Jun 30, 2022 | 139.77 Mn |
| Mar 31, 2022 | 167.74 Mn |
| Dec 31, 2021 | 174.31 Mn |
| Sep 30, 2021 | 106.56 Mn |
| Jun 30, 2021 | 116.72 Mn |
| Mar 31, 2021 | 122.68 Mn |